Literature DB >> 206078

Ethylmorphine-N-demethylation by liver homogenate of newborn and adult rats; Enzyme kinetics and age course of Vmax and Km1.

W Klinger, D Müller.   

Abstract

Optimum incubation conditions for determination of ethylmorphine-N-demethylation with newborn and adult rat liver homogenate have been determined: 1 ml 1:20 liver homogenate in 1.15% KCl, 1 ml 0.1 M phosphate buffer with ethylmorphine, NADP, and glucose-6-P, final concentrations 10, 0.33 and 5 mM, respectively, no nicotinamide, no MgCl2, 1 ml 0.5 M phosphate buffer; 3 ml final volume, 20 min incubation time. With both age groups NADH increases the activity to the same extent. With NADPH, saturation could be achieved only with newborn liver, but not with adult liver homogenate. Postnatally, the activity increases about fivefold, with a break at the 10th day of life. The Lineweaver-Burk plot was linear with newborn liver homogenate, whereas for all other age groups the graphs showed an angle. Statistical analysis pointed out that a two-enzyme model fits the experimental data only insignificantly better than a one-enzyme model. From other experimental evidence and manifold reproduction without any exception of these results, however, it may be concluded that there are different monooxygenases which show different affinities towards one substrate (ethylmorphine) and which show different developmental patterns.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 206078

Source DB:  PubMed          Journal:  Acta Biol Med Ger        ISSN: 0001-5318


  7 in total

1.  Developmental pharmacology and toxicology: biotransformation of drugs and other xenobiotics during postnatal development.

Authors:  Wolfgang Klinger
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jan-Jun       Impact factor: 2.441

2.  Single and chronic administration of ciprofibrate or of ciprofibrate-glycinate in male Fischer 344 rats: comparison of the effects on morphological and biochemical parameters in liver and blood.

Authors:  Amelie Lupp; Elke Karge; Manfred Danz; Thomas Deufel; Herbert Oelschläger; Wolfgang Klinger
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jul-Sep       Impact factor: 2.441

3.  Interaction of chlormezanone with rat liver microsomes and its degradation.

Authors:  W Klinger; H Oelschläger; E Karge; D Rothley
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Apr-Jun       Impact factor: 2.441

4.  Oral and dermal application of 2,4-dichlorophenoxyacetic acid sodium and dimethylamine salts to male rats: investigations on absorption and excretion as well as induction of hepatic mixed-function oxidase activities.

Authors:  D Knopp; F Schiller
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

5.  Interaction of chlormezanone enantiomers with rat liver microsomes.

Authors:  W Klinger; H Oelschläger; D Rothley; E Karge; A Seeling
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Jan-Mar       Impact factor: 2.569

6.  Monocyte-induced recovery of inflammation-associated hepatocellular dysfunction in a biochip-based human liver model.

Authors:  Marko Gröger; Knut Rennert; Benjamin Giszas; Elisabeth Weiß; Julia Dinger; Harald Funke; Michael Kiehntopf; Frank T Peters; Amelie Lupp; Michael Bauer; Ralf A Claus; Otmar Huber; Alexander S Mosig
Journal:  Sci Rep       Date:  2016-02-23       Impact factor: 4.379

7.  Liver dysfunction and phosphatidylinositol-3-kinase signalling in early sepsis: experimental studies in rodent models of peritonitis.

Authors:  Peter Recknagel; Falk A Gonnert; Martin Westermann; Sandro Lambeck; Amelie Lupp; Alain Rudiger; Alex Dyson; Jane E Carré; Andreas Kortgen; Christoph Krafft; Jürgen Popp; Christoph Sponholz; Valentin Fuhrmann; Ingrid Hilger; Ralf A Claus; Niels C Riedemann; Reinhard Wetzker; Mervyn Singer; Michael Trauner; Michael Bauer
Journal:  PLoS Med       Date:  2012-11-13       Impact factor: 11.069

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.